Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.23% | 182.09 | 0.7% | $1408.23m | |
| PFE | Pfizer Inc. | -0.17% | 51.61 | 0.9% | $1232.04m | |
| MRK | Merck & Co., Inc. | -0.81% | 92.52 | 0.7% | $1231.41m | |
| BMY | Bristol-Myers Squibb Co. | -0.17% | 78.86 | 1.0% | $1135.54m | |
| LLY | Eli Lilly & Co. | -0.10% | 325.35 | 1.1% | $1134.85m | |
| ABBV | AbbVie, Inc. | -0.04% | 152.49 | 1.9% | $1018.85m | |
| AZN | AstraZeneca Plc | -0.63% | 66.48 | 1.0% | $449.25m | |
| SGEN | Seagen Inc. | -1.61% | 176.45 | 5.7% | $320.77m | |
| GSK | GSK Plc | -0.44% | 43.50 | 0.2% | $296.14m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.00% | 75.17 | 0.0% | $291.93m | |
| MRTX | Mirati Therapeutics, Inc. | 2.70% | 70.00 | 1.6% | $204.79m | |
| SIGA | SIGA Technologies, Inc. | -10.81% | 11.63 | 0.0% | $195.93m | |
| HZNP | Horizon Therapeutics Plc | 0.00% | 85.13 | 5.4% | $182.59m | |
| NVS | Novartis AG | -0.04% | 84.79 | 0.2% | $167.69m | |
| NVO | Novo Nordisk A/S | 0.58% | 112.82 | 0.1% | $148.21m |
Company Profile
Checkpoint Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. Its product portfolio includes CK-301, CK-101, CK-103, CK-302, and Anti-CAIX. The company was founded on November 10, 2014 and is headquartered in Waltham, MA.